The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

Launched by EASTERN COOPERATIVE ONCOLOGY GROUP · Dec 30, 2024

Keywords

ClinConnect Summary

The ECOG-ACRIN SUPPORT Trial aims to improve participation in cancer clinical trials among Black and Latino patients. This study will involve about 500 patients from community oncology practices and will test a program that provides navigators and educational tools to help these patients learn more about clinical trials and how to get involved. The goal is to increase the number of Black and Latino patients referred to and enrolled in these important studies, which could lead to better cancer treatments for everyone.

To be eligible for this trial, participants must be at least 18 years old, identify as Black and/or Latino, and be receiving cancer care at a participating community oncology site. They should also be able to understand and sign an electronic consent form and have access to a device like a smartphone or computer to participate. Throughout the trial, participants can expect to receive support and information about clinical trials, helping them make informed decisions about their treatment options. This trial is not yet recruiting, so interested individuals will need to wait for further announcements on when they can join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participant must be ≥ 18 years of age. Participant must self-identify as Black and/or Latino. Participant must be an oncology patient at a participating NCORP. Participant must be eligible to participate in an ECOG-ACRIN clinical trial. Participant must have the ability to understand and the willingness to sign a e-consent document.
• • Participant must be receiving care at a participating NCORP affiliated community oncology site.
• • Participant must be English or Spanish speaking to be eligible. Participant must have access to a landline, smartphone, computer, or tablet.
• Exclusion Criteria:
• • -